Cytek Biosciences has introduced the Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ and Cytek Northern Lights™ systems. This upgrade allows researchers to detect subcellular particles, such as extracellular vesicles (EVs), with superior sensitivity and resolution. The global EV market is projected to grow significantly, from $227.5 million in 2023 to $1.3 billion by 2028, at a CAGR of 42.2%. This advancement positions Cytek as a leader in the small particle research market. The ESP Detection Option enhances the study of viruses, bacteria, and nanoparticles, offering unprecedented light scatter sensitivity and enabling more accurate measurement and characterization of small particles.